NRX Pharmaceuticals Inc (NRXP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $95.58M
Last updated: Nov 17, 2026 at 4:40 PM ET
NRX Pharmaceuticals Inc (NRXP) Statistics
NRX Pharmaceuticals (NRXP) has a market cap of $95.58M. Its share count is up 94.19% from a year earlier.
Total Valuation
| Market Cap | $95.58M |
|---|---|
| Latest price (Nov 17, 2026) | $2.45 |
Key Dates
The next earnings report is expected on Mar 22, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 22, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 16, 2026 |
| Fiscal Year End | December |
Valuation Ratios
The price to sales ratio is 24.5x.
| P/S Ratio | 24.5x |
|---|---|
| Forward P/S | 17.0x |
Price Statistics
The stock is down 1.61% over 52 weeks and trades 11.55% below its 50-day average.
| Beta (1Y) | 2.16 |
|---|---|
| 52-Week Change | -1.61% |
| 1-Month Change | -6.84% |
| 3-Month Change | -26.43% |
| 6-Month Change | -19.14% |
| 5-Year Change | -97.76% |
| Total Return (1Y) | -1.61% |
| Total Return (3Y CAGR) | -7.47% |
| Total Return (5Y CAGR) | -45.32% |
| Return vs SPY (1Y) | -4.10% |
| Max Drawdown (1Y) | -53.46% |
| Max Drawdown (3Y) | -83.44% |
| Sharpe Ratio (1Y) | 0.09 |
| Correlation with SPY (1Y) | 0.36 |
| 50-Day Average | $2.77 |
| 200-Day Average | $2.98 |
| 52-Week Range | $1.62 to $5.05 |
| RSI (14 Days) | 48.3 |
| Average Volume (20 Days) | 1.75M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.76x current liabilities.
| Current Ratio | 0.76x |
|---|---|
| Quick Ratio | 0.76x |
| Interest Coverage | -17.78x |
Returns and Efficiency
| Return on Assets (ROA) | -71.06% |
|---|---|
| Receivables Turnover | 20.33x |
Scores
NRXP has an Altman Z-Score of -17.40, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -17.40 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Stock Splits
The last split was a 1-for-10 reverse split on Apr 2, 2024.
| Last Split Date | Apr 2, 2024 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:10 |
Analyst Forecast
Consensus estimates put revenue growth at 695.35% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +695.35% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About NRXP
What is NRXP's market cap?
NRX Pharmaceuticals has a market cap of $95.58M.
How many shares of NRXP are outstanding?
NRX Pharmaceuticals has 43.17M shares outstanding. The count is up 94.19% from a year earlier.
Does NRXP pay a dividend?
No. NRX Pharmaceuticals does not pay a dividend.
NRXP pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors